Background
==========

Hox genes encode evolutionarily conserved homeodomain-containing transcription factors that pattern cells and tissues along the anterior--posterior body axis during metazoan development (for review, see \[[@B1],[@B2]\]). Hox proteins perform this function by serving as master regulators of expression of batteries of genes that impart identity to a cell \[[@B3],[@B4]\], and the precise regulation of Hox protein activity is therefore vital for proper development. Due to their central and conserved role in regional identity and fate specification during metazoan development, the mechanisms underlying the initiation, maintenance and modulation of Hox gene expression have been intensively studied \[[@B5]-[@B8]\]. In Drosophila, an elaborate network of maternally supplied and zygotically expressed transcription factors act to initiate Hox gene expression properly in the syncytial early embryo, while in the cellularized vertebrate embryo, secreted signaling molecules and growth factors are employed to coordinate precise Hox gene expression in time and space \[[@B9],[@B10]\]. In both vertebrates and Drosophila, once Hox gene expression is initiated, it is maintained by the Trithorax and Polycomb groups of chromatin regulatory proteins \[[@B11],[@B12]\], and can be further modulated by extracellular signaling pathways, Hox protein autoregulation and cross-regulation, and other mechanisms \[[@B5],[@B13]\].

As in other metazoans, Hox genes are essential during the development of the nematode *Caenorhabditis elegans*\[[@B14]\]. *C. elegans* has only six Hox genes, present in a dispersed cluster \[[@B15],[@B16]\]. Three Hox genes, *ceh-13*, *nob-1*, and *php-3*, are required for proper embryonic development \[[@B17]-[@B19]\]. The other three Hox genes, *lin-39*, *mab-5*, and *egl-5*, appear to be required only during post-embryonic development, however their expression begins in the embryo \[[@B20]-[@B22]\]. Very little is known about the initiation of Hox gene regulation in *C. elegans* in the embryo \[[@B23]\], although subsequent regulation of Hox gene expression in larval development by Polycomb and Trithorax-related proteins, signaling pathways, other transcription factors, microRNAs, and Hox proteins themselves, have all been noted \[[@B12],[@B23]-[@B40]\]. Elucidating the mechanisms by which Hox gene expression is initiated and regulated in nematodes will broaden our understanding of this important class of developmental regulators across a larger range of animal phyla, giving us further insight into their use during the evolution of animal diversity and their function in gene regulatory networks controlling pattern formation.

Our laboratory and others have studied the function of the Hox gene *lin-39* during nematode larval development, in particular during formation of the vulva, which is part of the hermaphrodite egg-laying apparatus. Vulval development begins in the first larval stage (L1) when the twelve ventral hypodermal blast cells, P1--P12 (P cells), divide to generate posterior daughters known as Pn.p cells \[[@B41]\]: the central six Pn.p cells, P3.p--P8.p, become Vulval Precursor Cells (VPCs) \[[@B42]\]. During the third larval stage (L3) the action of Wnt, Ras and Notch extracellular signaling pathways induces the VPCs to adopt distinct cell fates in the pattern 3°-3°-2°-1°-2°-3°, where the cells P5.p - P7.p adopt 1° and 2° (vulval) fates and divide to generate 22 cells that form the vulval opening, while P3.p, P4.p and P8.p adopt the non-vulval 3° fate, which is to divide once and fuse with the surrounding syncytial hypodermis (reviewed in \[[@B43],[@B44]\]). The Hox gene *lin-39* encodes a Deformed/Sex combs reduced ortholog expressed in the midbody region, including the six VPCs \[[@B20],[@B22]\]. *lin-39* acts twice during vulval development. *lin-39* is first required to generate the VPCs; in *lin-39* null mutants, the VPCs fuse with the hypodermis during the L1 stage, causing a Vulvaless (Vul) phenotype \[[@B20],[@B22]\]. Little is known about the regulation of *lin-39* expression at this time in development. *lin-39* is also required at the time of VPC fate specification in the L3; loss of *lin-39* activity at this time leads to defects in VPC fate specification \[[@B28],[@B45]\]. At this later time, LIN-39 acts downstream of RTK/Ras and Wnt extracellular signaling pathways \[[@B26],[@B28],[@B46],[@B47]\].

Trans-acting factors regulating *lin-39* expression have been identified previously using a variety of methods including forward and reverse genetic analysis, evolutionary conservation, and transgenic reporter analysis. Trans-acting factors regulating *lin-39* expression during vulval development include the RTK/Ras pathway transcriptional effectors LIN-1 and LIN-31 \[[@B28],[@B46]-[@B48]\], the Gli family member TRA-1 which acts downstream from the sex determination pathway \[[@B37]\], the zinc finger protein SEM-4 \[[@B49]\], the novel protein LIN-25 \[[@B47]\], several chromatin regulators \[[@B25],[@B32],[@B34],[@B48],[@B50]\], and LIN-39 itself \[[@B28],[@B47]\]. Direct binding to sites within the *lin-39* genomic region has been established in the case of LIN-1 (and LET-418, with which it interacts), LIN-31, LIN-39 and TRA-1 \[[@B37],[@B46]-[@B48]\].

We previously undertook to identify cis-acting sites regulating *lin-39* expression \[[@B47]\]. Due to the large size of the *lin-39* genomic region (\~28 kb) we inserted fragments of *lin-39* genomic DNA upstream of an enhancerless GFP reporter. By that method, we identified three functional elements: a 340 bp upstream fragment (JW3.9) that directs expression in P cells in the embryo and in their larval descendants including the VPCs, a 247 bp site from the first *lin-39* intron that directs expression in larval ventral cord neurons, and a 1.3 kb promoter fragment (JW5) that drives expression in P6.p at the time of vulval induction. Expression from the last element is dependent on Ras pathway function and we showed that LIN-1, LIN-31 and LIN-39 directly bind this cis-regulatory module. Using an alternative approach, Kuntz et al. used phylogenetic analysis to identify a number evolutionarily-conserved regions in the *lin-39* genomic region, and showed that several of these sites also drove expression in certain cells or tissue when inserted upstream of an enhancerless GFP reporter \[[@B51]\]. These approaches both require that the site in question be able to mediate proper transcription activation of the reporter gene *in vivo*, and this requirement may lead to false negative results. To circumvent this issue, here we use the yeast one-hybrid assay, in which transcription factors that directly bind to a site of interest are identified, and then the function of these factors in gene regulation *in vivo* can be assayed \[[@B52]\].

In our previous analysis of the *lin-39* genomic region, we identified a number of short DNA sequences in the *lin-39* region that were strongly conserved between *C. elegans* and two other nematode species (\[[@B47]\], Supplemental material). Starting with these evolutionarily conserved elements and the 340 bp JW3.9 fragment, we used manual \[[@B53]\] and robotically-assisted "enhanced Y1H" (eY1H) \[[@B54]\] screens to identify 16 *C. elegans* transcription factors that bind to specific *lin-39* genomic DNA fragments. Seven of these factors were characterized further to determine a role in *lin-39* regulation during vulval development. We found that the orphan nuclear receptor NHR-43, the hypodermal fate regulator LIN-26 and the GATA factor ELT-6 positively regulate *lin-39* expression in the embryo and may play a role in initiation of *lin-39* in the vulval lineage. In the larva, NHR-43, LIN-26, ELT-6, the zinc finger proteins ZTF-17 and BED-3, and the T box factor TBX-9 positively regulate *lin-39* expression in the VPCs. Interestingly, we previously showed that the adjacent GATA factor genes *egl-18* and *elt-6* are downstream targets of LIN-39 in the larva VPCs \[[@B55]\]. Combined with our current result that ELT-6 binds to and regulates *lin-39* expression in the embryo, this suggests that EGL-18/ELT-6 and LIN-39 may form a positive feedback loop to initiate and maintain *lin-39* gene expression during embryonic and larval life to ensure proper VPC fate specification.

Results
=======

Identification of transcription factors that bind to *lin-39* genomic regions using yeast one-hybrid screens
------------------------------------------------------------------------------------------------------------

We previously identified cis and trans-acting factors that regulate *lin-39* expression in response to RTK/Ras signaling in the larval VPCs \[[@B47]\]. To further understand Hox gene *lin-39* regulation in *C. elegans*, we sought to identify transcription factors that bind to and regulate *lin-39* expression, with an emphasis on 1) regulation in the vulval precursor cells P3.p - P8.p (VPCs) and their descendants in the larva, and 2) expression in the precursors to the VPCs, the P cells P3 - P8, in the embryo. We used the yeast one-hybrid approach, in which DNA sequences from the gene of interest are used as 'bait' to screen for factors that can bind these sequences in yeast leading to activation of reporter gene expression \[[@B53]\]. Previously, in addition to identifying large genomic regions that drove GFP reporter expression in *lin-39*-expressing cells, we also identified 31 short DNA elements (\<50 bp) located upstream, downstream and in introns that are conserved in *lin-39* from the species *C. elegans*, *C. briggsae* and *C. remanei*\[[@B47]\] (Additional file [1](#S1){ref-type="supplementary-material"}: Figure S1). Reasoning that some of these evolutionarily conserved regions (ECRs) may be binding sites for transcription factors that regulate *lin-39* expression, we used twelve small *lin-39* genomic regions (range 150--460 bp) that each encompassed one or more ECRs in yeast one-hybrid screens (Table [1](#T1){ref-type="table"}, Additional file [1](#S1){ref-type="supplementary-material"}: Figure S1). We also used the element JW3.9, a 340 bp fragment found 7.4 kb upstream of *lin-39* that drives GFP expression in the P cells of the embryo \[[@B47]\], as this fragment may bind factors responsible for initiation of *lin-39* expression (Additional file [1](#S1){ref-type="supplementary-material"}: Figure S1). These thirteen DNA fragments, which together represent \~ 13% of the genomic region between *lin-39* and its neighboring genes, were used as separate 'baits' (Table [1](#T1){ref-type="table"}).

###### 

**Seven transcription factors interact with*lin-39*genomic DNA in yeast one-hybrid assays**

  **Fragment**   **ECRs**         **Size**   **TFs bound**
  -------------- ---------------- ---------- --------------------
  **YF1**        **ECR1**         **342**    **NHR-43**
  **YF2**        **ECR2**         **311**    **ALR-1**
  **YF3**        **ECR4**         **253**     
  **YF4**        **ECR7 - 10**    **372**    **ZTF-17, LIN-26**
  **YF5**        **ECR11,12**     **298**     
  **YF6**        **ECR16**        **304**     
  **YF7**        **ECR17**        **158**     
  **YF8**        **ECR18 - 20**   **331**     
  **YF9**        **ECR21 - 23**   **257**    **TBX-9**
  **YF10**       **ECR24 - 26**   **319**    **BED-3**
  **YF11**       **ECR27,28**     **254**     
  **YF12**       **ECR29 - 33**   **455**     
  **JW3.9**      **-**            **338**    **ELT-6**

The table indicates the 13 fragments (YF1-12, JW3.9) used in yeast one-hybrid screens, the evolutionarily-conserved regions (ECRs) each contains, the size of the fragment used, and the transcription factors identified as binding to each fragment.

We used two yeast one-hybrid assay procedures. One screen was performed by transformation of the thirteen bait strains with a library of 755 plasmids that each express one *C. elegans* transcription factor fused to the activation domain from the yeast transcription factor GAL4 \[[@B53],[@B56]\]. Two other screens were performed using a robotically-assisted mating assay in which the thirteen haploid bait strains were mated to a collection of 936 strains, each of which expresses a single *C. elegans* transcription factor fused to the GAL4 activation domain \[[@B54]\]. Factors identified as positive from the primary screens were retransformed manually and tested a second time; only factors that showed a reproducible interaction in yeast were considered true positives. In total, 18 interactions were found in yeast between 16 transcription factors and eight different fragments (site bound by each factor is shown in parenthesis): NHR-43 (YF1), ALR-1 (YF2), and ZTF-17 (YF4) were identified through the library transformation screen, while 13 factors were identified via the robotically-assisted mating screens: ODR-7, TBX-39 and TBX-40 (YF1); LIN-26 (YF4); TBX-11, TBX-39 and EGL-43 (YF7); FLH-1 and NHR-111 (YF8); TBX-9 and the protein encoded by B0238.11 (YF9); BED-3 and FLH-1 (YF10); DMD-3 and ELT-6 (JW3.9) (Additional file [2](#S2){ref-type="supplementary-material"}: Figure S2 and Additional file [3](#S3){ref-type="supplementary-material"}: Figure S3, Additional file [4](#S4){ref-type="supplementary-material"}: Table S2 and S3, summary in Additional file [4](#S4){ref-type="supplementary-material"}: Table S4).

We describe here our characterization of seven transcription regulators (Table [1](#T1){ref-type="table"}) chosen because these factors had either known expression in *lin-39*-expressing cells or a phenotype affecting a *lin-39*-regulated process \[[@B57]\], or because our preliminary data showed an effect on *lin-39* reporter expression *in vivo*. For each factor we carried out the following analyses. To validate the yeast interactions we expressed and purified each factor from bacteria and assayed binding to the appropriate sites *in vitro* (Figure [1](#F1){ref-type="fig"}, Additional file [5](#S5){ref-type="supplementary-material"}: Figure S6). To determine if these factors regulate *lin-39* expression *in vivo* in the vulval precursor cells during larval life, we reduced function for each transcription factor and examined *lin-39* expression using an integrated transcriptional *lin-39::GFP* reporter (*deIs4*) that contains 250 kb of genomic DNA around the *lin-39* locus \[[@B46]\] (Figures [2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}). We also examined *lin-39* expression in RNAi-treated and mutant animals at the L3 stage by qRT-PCR (Figure [4](#F4){ref-type="fig"}). The strain containing the integrated *lin-39::GFP* reporter was also used to examine the effects of reduced transcription factor activity on *lin-39* expression in the embryonic P cells P5 - P8, which divide in the larva to generate *lin-39*-expressing vulval precursor cells and ventral cord neurons \[[@B46]\] (Tables [2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}, Figure [5](#F5){ref-type="fig"}). Finally, we examined the effect of reduction of factor function in a *lin-39*-sensitized background on the fusion of the vulval precursor cells at the L2 stage (Table [4](#T4){ref-type="table"}). Below we describe our results that show that six of the factors identified in the yeast one-hybrid screens regulate *lin-39* expression in the larval vulval precursor cells, while three of them also regulate *lin-39* expression in the embryo.

![**LIN-39 regulators identified in yeast bind to*lin-39*promoter regions*in vitro*. A - F)** Gel mobility shift assays with proteins expressed and purified from *E. coli*. Arrowhead indicates free probe; arrow indicates protein DNA complexes. For each panel, the top line identifies the labeled probe used, the bottom line shows the amount of protein added in each lane; middle lines (panels **A**, **B**, **D** and **F**) indicate the identity and amount of competitor added. **A)** NHR-43 binds to YF1 (342 bp). Lanes 3--5 contain cold wild type YF1 as competitor, while lanes 6--8 contain cold YF1 with the TGAC site mutated as competitor; **B)** ALR-1 binds to ECR2 (40 bp); this binding is competed by wild type ECR2 but not by a scrambled oligonucleotide with the same nucleotide composition (ECR2S); **C)** ZTF-17 binds to YF4-2 (186 bp) and YF4-4 (110 bp); **D)** ZTF-17 binding to YF4-2 is competed by YF4-4 but not YF4-3; **E**) LIN-26 binds to YF4-3-1 (51 bp); **F)** LIN-26 binding to YF4-3-1 is competed by YF4-3-1 (51 bp) but not YF4-3-2 (52 b); **G)** Fragment YF4 with ECRs 7--10 is shown above, with smaller subfragments diagrammed below. Shading indicates fragments that were bound by ZTF-17 and/or LIN-26 in yeast one-hybrid assays and *in vitro*.](1471-213X-14-17-1){#F1}

![**Seven transcription factors affect*lin-39::GFP*expression in the VPCs at early L3 stage.** GFP expression in the VPCs P5.p - P8.p from *smg-1; deIS4* (*lin-39::GFP*) animals treated for RNAi of individual transcription factors identified in yeast (panels **B-H**), or given control RNAi (empty vector; panel **A**). Early L3 stage animals are shown; anterior is left, ventral is down. These animals also express *ajm-1::GFP*, which outlines cell junctions of hypodermal cells and the pharynx (bright staining in the anterior seen in most panels). RNAi for *lin-26*, *bed-3*, and *tbx-9* causes severe embryonic lethal and larva arrest phenotypes, so RNAi for these genes was performed by feeding newly-hatched L1 larvae on RNAi bacterial lawns and examining GFP expression in these same animals at the L3 stage. For all other genes, RNAi treatment was carried out on P0 animals, and their F1 progeny were examined as L3 animals. All pictures were taken under the same exposure.](1471-213X-14-17-2){#F2}

![**Seven transcription factors affect*lin-39::GFP*expression in the VPCs at early L3 stage.***smg-1; deIs4*(*lin-39::GFP*) animals were treated for RNAi of individual transcription factors (panels **A--G**, dark bar), or control RNAi (panels **A--G**, light bar) as in Figure [2](#F2){ref-type="fig"}. Early L3 stage animals were photographed at the same exposure, and pixel counts in each VPC were determined using ImageJ (\>20 animals for each strain). Bars show mean GFP pixel count in each cell with standard deviation. '\*' indicates *P-value* \< 0.05. '\*\*' indicates *P-value* \< 0.001, compared to control animals.](1471-213X-14-17-3){#F3}

![**Regulation of*lin-39*levels by transcription factors*in vivo*(qRT-PCR)*.*A)** Decrease in *lin-39* transcript levels in *nhr-43*, *lin-26*, *tbx-9*, *bed-3* mutant and *ztf-17(RNAi)* animals. **B)** Decrease in *lin-39* transcript levels when activity of both *elt-6* and *egl-18* is reduced. **C)** Increase in *lin-39* transcript levels when either *elt-6* or *egl-18* was overexpressed from the heat shock promoter. All analyses were done on L3 stage animals. The mean values for each genotype were obtained from at least two independent experiments and normalized to the housekeeping gene, *gpd-2*, as internal standard. The data was analyzed with unpaired t-test compared to the appropriate control. '\*' indicates *P-value* \< 0.05.](1471-213X-14-17-4){#F4}

###### 

**Decreases in*lin-39::GFP*expression in embryonic P cells in transcription factor RNAi animals**

  **RNAi**       **N**    **% eggs with WT expression in P5-P8**
  -------------- -------- ----------------------------------------
  **Control**    **46**   **100%**
  ***nhr-43***   **40**   **80%\***
  ***alr-1***    **36**   **100%**
  ***ztf-17***   **36**   **100%**
  ***lin-26***   **36**   **86%\***
  ***tbx-9***    **37**   **100%**
  ***bed-3***    **36**   **94%**
  ***elt-6***    **51**   **82%\***
  ***egl-18***   **37**   **100%**

*smg-1*; *lin-39::GFP* animals were grown on bacteria expressing dsRNA for each transcription factor or the control vector and GFP expression in the P cells (P5 -- P8) of embryos laid by these animals was examined. The percentage of animals having a wild-type intensity of GFP in all four P cells based on visual observation is indicated. 'N' = number of embryos scored. '\*' indicates P \< 0.05 compared to control (Fisher's exact test).

###### 

**Decreases in*pJW3.9::GFP*expression in*elt-6*and*egl-18*mutants in embryonic P cells**

  **Background**       **RNAi**       **N**    **% eggs with WT expression in P5-P8**
  -------------------- -------------- -------- ----------------------------------------
  **Wild-type**        **-**          **50**   **98%**
  **Wild-type**        **Control**    **36**   **94%**
  **Wild-type**        ***elt-6***    **50**   **78%\***
  **Wild-type**        ***egl-18***   **36**   **91%**
  ***elt-6(gk723)***   **Control**    **34**   **56%\***
  ***elt-6(gk723)***   ***egl-18***   **36**   **58%\***
  ***egl-18(n162)***   **Control**    **38**   **68%\***
  ***egl-18(n162)***   ***elt-6***    **36**   **69%\***
  ***egl-18(ga97)***   **Control**    **20**   **60%\***
  ***egl-18(ga97)***   ***elt-6***    **24**   **54%\***

Animals containing *pJW3.9::GFP* in either wild type, *elt-6* mutant (*gk723*) or *egl-18* mutant (*n162* and *ga97*) backgrounds were synchronized and given the indicated RNAi treatment. *pJW3.9::GFP* expression in P5 - P8 was scored at bean stage in the embryos laid by these animals. 'N' = number of embryos scored. The percentage of animals having a wild-type intensity of GFP in all four P cells based on visual observation is indicated in column four. '\*' indicates P \< 0.05 compared to control (Fisher's exact test).

![**NHR-43, LIN-26, ELT-6 and EGL-18 are necessary for*lin-39::GFP*expression in the embryo. A--D)** GFP expression in embryos derived from *smg-1; deIs4*(*lin-39::GFP*) animals treated for control RNAi (empty vector, panel **A**) or for RNAi against transcription factor genes **B)***nhr-43;***C)***lin-26* or **D)***elt-6*. **E -- H)** GFP expression in embryos carrying *pJW3.9::GFP* in a wild-type background **(E)** or in animals carrying mutations in *elt-6***(F)** or *egl-18***(G and H)**. Embryos shown are at the 'bean' stage of embryogenesis (\~360 minutes). All photos were taken under identical exposure settings. Note that before the individual P cells interdigitate at the ventral midline, the cells are referred to by their possible fates (i.e., P5/6 L and P5/6R), and there are two GFP-expressing cells on the left side and two on the right.](1471-213X-14-17-5){#F5}

###### 

**Reduction of transcription factor function in a*lin-39*sensitized background affects VPC fusion**

  **Strain**                           **% WT VPCs**
  ----------------------------------- ---------------
  ***lin-39(n709ts) FV(RNAi)***           **96%**
  ***lin-39(n709ts) nhr-43(RNAi)***       **88%**
  ***lin-39(n709ts) alr-1(RNAi)***       **72%\***
  ***lin-39(n709ts) ztf-17(RNAi)***       **80%**
  ***lin-39(n709ts) lin-26(RNAi)***      **65%\***
  ***lin-39(n709ts) tbx-9(RNAi)***       **72%\***
  ***lin-39(n709ts) bed-3(RNAi)***       **72%\***
  ***lin-39(n709ts) elt-6(RNAi)***       **56%\***

*lin-39(n709ts); wIs79(ajm-1::GFP)* animals were grown for two generations at 25° on *E. coli* expressing dsRNA targeting the indicated gene (except for *bed-3* and *lin-26* which were grown one generation due to lethality). Larvae at the mid L2 stage (17 hrs after feeding of newly hatched L1s) were examined for *ajm-1::GFP* expression in the vulval precursor cells. Wild type animals have either 5 or 6 VPCS with *ajm-1::GFP* expression at this time (due to fusion of P3.p with hyp7). The percentage of animals showing the wild type pattern is shown (n ≥ 25 animals). '\*' indicates P \< 0.05 compared to feeding vector (FV) control (Fisher's exact test).

Orphan nuclear hormone receptor NHR-43 positively regulates *lin-39* expression in the embryo and larva
-------------------------------------------------------------------------------------------------------

The *nhr-43* gene encodes an orphan nuclear hormone receptor, and *nhr-43::GFP* reporter expression is present from late embryo to adult in hypodermis, excretory cells, posterior intestine cells, and two head neurons \[[@B58],[@B59]\]. In yeast, NHR-43 bound to YF1, a 342 bp fragment located 8.6 kb upstream of *lin-39* (Additional file [1](#S1){ref-type="supplementary-material"}: Figure S1 and Additional file [2](#S2){ref-type="supplementary-material"}: Figure S2), and this binding was verified *in vitro* using NHR-43 protein purified from *E. coli* (Figure [1](#F1){ref-type="fig"}A). Some nuclear hormone receptors are known to bind sites containing the sequence TGAC \[[@B60]\], and there is a TGAC site in YF1. While the wild type YF1 sequence competed for NHR-43 binding *in vitro*, the same YF1 fragment with the TGAC site mutated no longer competed effectively (Figure [1](#F1){ref-type="fig"}A), suggesting that NHR-43 may bind to YF1 through this putative NHR binding site.

When RNAi was performed on worms carrying the *lin-39::GFP* transcriptional reporter to reduce *nhr-43* function, their progeny showed a decrease in the number of animals expressing wild type levels of GFP in the vulval precursor cells at the L3 stage (Figures [2](#F2){ref-type="fig"}B and [3](#F3){ref-type="fig"}A). qRT-PCR on *nhr-43(tm1381)* mutant animals \[[@B57]\] at the L3 stage also showed a decrease in *lin-39* expression compared to control animals (Figure [4](#F4){ref-type="fig"}A). We also found that fewer embryos derived from hermaphrodites treated with *nhr-43* RNAi showed *lin-39::GFP* expression in P5 - 8 compared to control animals (Figure [5](#F5){ref-type="fig"}B, Table [2](#T2){ref-type="table"}), indicating that *nhr-43* positively regulates *lin-39::GFP* in the embryonic P cells. This embryonic defect could explain the reduction in GFP expression in the VPCs in the larva, however a decrease in *lin-39::GFP* expression was also observed if *nhr-43* RNAi was performed on L1 worms and then the same animals were observed in the L3 stage (51% of *nhr-43(L1 RNAi)* animals showed wild type expression in all VPCs versus 76% of RNAi control, p \< 0.001). In summary, orphan nuclear hormone receptor NHR-43 binds to a site located far upstream of the *lin-39* initiation codon, and *nhr-43* function is required for wild type levels of *lin-39* expression in the embryo and larva in cells that will participate in vulval development.

The Aristaless homolog ALR-1 may regulate larval *lin-39* expression
--------------------------------------------------------------------

*alr-1* encodes a factor homologous to the products of the Drosophila *aristaless* and mouse *ARX* (*aristaless-related*) genes, and antibody staining and GFP reporter analysis have shown *alr-1* expression in multiple neurons and hypodermal cells from embryo to adult \[[@B61],[@B62]\]. In yeast, ALR-1 bound to YF2, a 311 bp DNA fragment located 6.4 kb upstream of *lin-39* containing the evolutionarily conserved sequence ECR2 (Additional file [1](#S1){ref-type="supplementary-material"}: Figure S1 and Additional file [2](#S2){ref-type="supplementary-material"}: Figure S2). Recently, the modENCODE project identified genomic binding sites for a number of *C. elegans* transcription factors, including ALR-1, using chromatin immunoprecipitation from larval animals \[[@B40],[@B63]\]. Examination of this data shows binding of ALR-1 to multiple sites in the *lin-39* promoter region, including the ECR2 site. Bacterially expressed ALR-1 protein bound to a 40 bp DNA fragment encompassing ECR2 *in vitro*, and this binding was not competed by 100 fold excess of an oligonucleotide of the same base composition and length but scrambled sequence (Figure [1](#F1){ref-type="fig"}B). Therefore, ALR-1 binds a site in the upstream region of *lin-39* in both *in vitro* and *in vivo* assays.

We did not observe a significant effect of *alr-1* RNAi on *lin-39* or *lin-39::GFP* expression in either the embryo or larva in the cells that will give rise to the vulva (Figures [2](#F2){ref-type="fig"}C, [3](#F3){ref-type="fig"}B, and [4](#F4){ref-type="fig"}A, Table [2](#T2){ref-type="table"}). However, we did observe an effect of *alr-1* RNAi on a *lin-39* mediated process in the larval VPCs. During wild type development, the cells P3.p - P8.p are born in the L1 stage and because they express *lin-39* they do not fuse with the surrounding hyp7 syncytium as more anterior and posterior Pn.p cells do \[[@B20],[@B22]\]. Later, in approximately 50% of animals, P3.p can fuse with hyp7 in the L2 stage \[[@B42]\]. Thus wild type animals have either five or six VPCs at the time of vulval induction in the late L2 stage. In *lin-39* mutant animals, or in animals in which Wnt signaling is compromised, additional VPCs are seen to adopt this Fused fate \[[@B26],[@B28],[@B45]\]. To examine the role of potential *lin-39* regulators in this process we used RNAi to reduce their function in a sensitized strain containing the hypodermal junction marker *ajm-1::GFP* and the temperature sensitive mutation *lin-39(n709ts)* and examined the fusion of the VPCs at the L2 stage as before \[[@B55]\]. We found an increased number of larva with VPC fusion defects in *lin-39(ts) alr-1(RNAi)* compared to *lin-39(ts)* control animals (Table [4](#T4){ref-type="table"}). Therefore, although we were unable to detect an effect of loss of ALR-1 function on *lin-39* expression in the vulval cells, we did see a weak effect on a LIN-39 dependent process, leaving open its role as an *in vivo* regulator of *lin-39* expression.

The zinc finger protein ZTF-17 positively regulates *lin-39* expression
-----------------------------------------------------------------------

*ztf-17* encodes a zinc finger transcription factor, and a *ztf-17::GFP* transcriptional reporter is expressed in head muscle, pharynx, and the ventral nerve cord \[[@B64]\]. In yeast, ZTF-17 bound to YF4, a 372 bp DNA fragment located 2 kb upstream of *lin-39* that contains ECRs 7--10 (Additional file [1](#S1){ref-type="supplementary-material"}: Figure S1 and Additional file [2](#S2){ref-type="supplementary-material"}: Figure S2). To identify a smaller ZTF-17 binding region, we divided YF4 into smaller fragments, and showed by one-hybrid assays that ZTF-17 interacts with YF4-4, a 110 bp subfragment that overlaps ECR10 (Figures [1](#F1){ref-type="fig"}C and E, Additional file [6](#S6){ref-type="supplementary-material"}: Figure S4). *in vitro* binding and competition assays with bacterially-expressed ZTF-17 protein validated this result, showing that ZTF-17 binds to fragment YF4-4, but not the adjacent fragment YF4-3 Figure [1](#F1){ref-type="fig"}C and D).

*ztf-17* RNAi performed on *lin-39::GFP* worms caused a decrease in the number of progeny animals showing wild type levels of *lin-39::GFP* expression in the VPCs, (Figures [2](#F2){ref-type="fig"}D and [3](#F3){ref-type="fig"}C), and qRT-PCR analysis of these *ztf-17(RNAi)* animals showed a statistically significant decrease in *lin-39* at the L3 stage (Figure [4](#F4){ref-type="fig"}A). *lin-39::GFP* expression in the VPC parent cells, P5 - P8, was not altered in embryos derived from *ztf-17(RNAi)* mothers (Table [2](#T2){ref-type="table"}), suggesting that ZTF-17 may be a larval regulator of *lin-39* expression. In summary, *in vitro* and yeast one-hybrid analyses indicate that the zinc finger protein ZTF-17 binds to a 110 bp fragment located upstream of *lin-39*, and positively regulates *lin-39* expression in the vulval precursor cells during larval life.

LIN-26, which is required for maintenance of hypodermal cell fates, may positively regulate *lin-39* expression in the embryo and larva
---------------------------------------------------------------------------------------------------------------------------------------

*lin-26* encodes a zinc-finger protein which is expressed in all hypodermal cells based on antibody staining \[[@B65],[@B66]\]. In *lin-26* mutants, cell fate transformations from hypodermal to neuronal fate occur in many cells, including the VPCs \[[@B65],[@B66]\]. LIN-26 also bound to YF4 in the yeast one-hybrid assay (Additional file [1](#S1){ref-type="supplementary-material"}: Figure S1 and Additional file [7](#S7){ref-type="supplementary-material"}: Figure S5), and further analysis showed an interaction with YF4-3, a 103 bp DNA fragment that is distinct from the fragment bound by ZTF-17 (Figure [1](#F1){ref-type="fig"}G, Additional file [5](#S5){ref-type="supplementary-material"}: Figure S5). We divided fragment YF4-3 into two smaller fragments, and *in vitro* DNA binding and competition experiments showed that LIN-26 bound to YF4-3-1, a 51 bp DNA fragment that does not contain an evolutionarily conserved region (Figure [1](#F1){ref-type="fig"}E and F).

To assay *lin-26* regulation of *lin-39* expression *in vivo*, *lin-26* RNAi was performed on newly hatched *lin-39::GFP* larvae and GFP levels in VPCs P5.p-P8.p were examined at the L3 stage in the same animals; this 'L1 feeding' was performed because of the embryonic lethal phenotype caused by *lin-26* RNAi. *lin-26* RNAi caused a weak but significant decrease in expression of *lin-39::GFP* in P5.p and P6.p at the L3 stage (Figures [2](#F2){ref-type="fig"}E and [3](#F3){ref-type="fig"}D), and qRT-PCR performed on *lin-26(n156)* mutant animals \[[@B65]\] also showed a small but significant decrease in *lin-39* at the early L3 stage (Figure [4](#F4){ref-type="fig"}A). Finally, we investigated *lin-26* regulation of *lin-39* in the embryo, and found that fewer embryos expressed *lin-39::GFP* in the P cells from mothers treated with *lin-26* RNAi, compared to control embryos (Figure [5](#F5){ref-type="fig"}C; Table [2](#T2){ref-type="table"}). Consistent with effects on *lin-39* expression, *lin-26(RNAi)* performed on newly hatched L1 larvae in a sensitized *lin-39* background caused a defect in VPC fusion at the L2 (Table [4](#T4){ref-type="table"}). Thus, we have identified a binding site in the *lin-39* upstream region for the general hypodermal transcription factor LIN-26, and our results suggest that LIN-26 acts to positively regulate *lin-39* expression in both the embryo and larva.

The T-box protein TBX-9 binds in *lin-39* intron 2 and positively regulates larval *lin-39* expression in the VPCs
------------------------------------------------------------------------------------------------------------------

*tbx-9* encodes a T-box transcription factor, and a *tbx-9::GFP* translational reporter is expressed in lateral and ventral hypodermal cells, intestine and muscle \[[@B67]\]. *tbx-9* mutants have a disorganized body shape beginning in the embryo, which was attributed to defects in hypodermal cells and body wall muscles \[[@B67]\]. In yeast, TBX-9 bound to YF9, a 257 bp DNA fragment located in the large second intron of *lin-39* that contains ECRs 21--23 (Additional file [1](#S1){ref-type="supplementary-material"}: Figure S1 and Additional file [2](#S2){ref-type="supplementary-material"}: Figure S2), and this binding was recapitulated *in vitro* with purified TBX-9 protein (Additional file [5](#S5){ref-type="supplementary-material"}: Figure S6). We divided the YF9 fragment into four smaller fragments (A-D), and found that bacterially purified TBX-9 bound best to the 79 bp subfragment C, and that this fragment could also compete for binding of TBX-9 to YF9 (Additional file [5](#S5){ref-type="supplementary-material"}: Figure S6).

To test TBX-9 as a regulator of *lin-39 in vivo*, *tbx-9* RNAi was performed on L1 *lin-39::GFP* worms, and we observed a decrease in the number of animals with wild type levels of GFP expression in P5.p-P8.p in the same animals at the L3 stage (Figures [2](#F2){ref-type="fig"}F and [3](#F3){ref-type="fig"}E). qRT-PCR analysis on *tbx-9(ok2473)* mutant animals \[[@B57]\] also showed a decrease in *lin-39* levels compared to wild type L3 stage worms (Figure [4](#F4){ref-type="fig"}A), and *tbx-9(RNAi)* performed in a sensitized *lin-39* background caused a defect in VPC fusion at the L2 (Table [4](#T4){ref-type="table"}). *tbx-9* RNAi treatment did not effect *lin-39::GFP* expression in the cells P5-P8 in the embryo (Table [2](#T2){ref-type="table"}). In summary, we found that TBX-9 may bind multiple sites within a 257 bp fragment from *lin-39* intron 2, and TBX-9 acts as a positive regulator of *lin-39* expression in the VPCs in the larva.

The Zinc-finger protein BED-3 binds to site in *lin-39* intron 2 and positively regulates *lin-39* expression
-------------------------------------------------------------------------------------------------------------

*bed-3* encodes a BED zinc-finger protein that is expressed in most hypodermal cells, including the seam cells and the progeny of the VPCs at the time of L3/L4 molt \[[@B68]\]. In *bed-3* mutants, the granddaughters of P5.p, P6.p and P7.p often fail to divide, which suggested that BED-3 acts late during vulval induction in the terminal divisions of the induced VPCs \[[@B68]\]. In yeast, BED-3 bound YF10, a 319 base pair fragment from the second *lin-39* intron that contains ECRs 24--26 (Additional file [1](#S1){ref-type="supplementary-material"}: Figure S1 and Additional file [2](#S2){ref-type="supplementary-material"}: Figure S2). Bacterially-expressed BED-3 protein bound to YF10 *in vitro*, however, we found that BED-3 protein also bound to several other unrelated DNA fragments, suggesting the purified BED-3 protein may show non-specific binding *in vitro* (data not shown).

Despite our inability to validate the BED-3 binding result *in vitro*, we observed that *bed-3* RNAi caused a strong decrease in the number of animals with wild type levels of *lin-39::GFP* expression in P5.p-P8.p at the L3 stage (Figures [2](#F2){ref-type="fig"}G and [3](#F3){ref-type="fig"}F), and this decrease was also seen by qRT-PCR analysis on *bed-3(sy702)* L3 larvae (Figure [4](#F4){ref-type="fig"}A). Consistent with the decrease in *lin-39* expression *in vivo*, *bed-3(RNAi)* caused a defect in VPC fusion at the L2 in a sensitized *lin-39* background (Table [4](#T4){ref-type="table"}). However *lin-39::GFP* expression did not change in embryos derived from mothers treated for *bed-3(RNAi)* (Table [2](#T2){ref-type="table"}). Therefore, although we could not localize a binding site for BED-3 beyond the *lin-39* intron 2 fragment used in the yeast screen, our *in vivo* data indicate that BED-3 is likely to function as a positive regulator of *lin-39* expression in the vulval precursor cells in the larva.

The GATA factor ELT-6 binds to a *lin-39* enhancer that directs expression in the P cells in the embryo
-------------------------------------------------------------------------------------------------------

We previously described a 340 bp cis-regulatory element from *lin-39* that is sufficient to drive GFP expression in the embryo in P5-P8, cells which divide to generate *lin-39* expressing VPCs and neuroblasts in the ventral midbody region (construct *pJW3.9*, \[[@B47]\]). A 24 bp sequence (S1) in the *pJW3.9* enhancer is conserved between *C. elegans* and *C. briggsae*, and mutation of this site abolished embryonic expression from the *pJW3.9* reporter \[[@B47]\]. Site S1 contains the sequence TGATAA, a predicted binding site for a GATA family transcription factor, which prefer the motif WGATAR \[[@B69]\]. Intriguingly, we found that the transcription factor ELT-6 bound to the *pJW3.9* enhancer fragment in our yeast screen (Additional file [1](#S1){ref-type="supplementary-material"}: Figure S1 and Additional file [2](#S2){ref-type="supplementary-material"}: Figure S2). *elt-6* encodes a 367 amino acid GATA transcription factor expressed in certain neurons and hypodermal cells, particularly the seam cells and VPCs \[[@B55],[@B70]\]. We performed directed yeast one-hybrid assays with eight other *C. elegans* GATA factors and found that ELT-6 was the only GATA factor that interacted with the *pJW3.9* enhancer fragment in yeast (Additional file [4](#S4){ref-type="supplementary-material"}: Table S5). When the GATA site in *pJW3.9* was mutated in the yeast reporters, ELT-6 no longer interacted with the DNA fragment in yeast (Figure [6](#F6){ref-type="fig"}A). ELT-6 protein purified from *E. coli* bound the S1 site *in vitro*, but did not bind when the GATA sequence was mutated (Figure [6](#F6){ref-type="fig"}B). ELT-6 binding to S1 was abolished when competed with excess wild type cold S1 probe, but when the S1 GATA site was mutated, the resulting oligonucleotide (M1) competed less well for ELT-6/S1 binding (Figure [6](#F6){ref-type="fig"}C). When a second GATA site at the edge of the 40 bp oligonucleotide was also mutated, the ability of the mutated oligonucleotide (M2) to compete was greatly reduced (Figure [6](#F6){ref-type="fig"}C).

![**ELT-6 interacts with*pJW3.9*through a GATA binding site. A)** Yeast strains containing *HIS3* and *lacZ* reporters transformed with empty vector (Control) or ELT-6::GAL4AD plasmids (ELT-6) were diluted and replica plated to control (left), 10 mM 3aminotriazole (3AT, middle), and XGal (right) plates. Reporters had inserts of either JW3.9 (top) or JW3.9 in which GATA binding site S1 was mutated from TGATAA to GGTACC ('Mut' bottom). Mutation of the GATA site abolishes the interaction with ELT-6 based on lack of growth on 3AT and lack of blue color on XGal.; **B)** Increasing concentrations of ELT-6 interact with a 40 bp fragment around GATA site S1 (lanes 2-6). Mutation of the GATA site S1 from TGATAA to GGTACC (M1) abolishes interaction with ELT-6 (lane 8); **C)** 50 ng of cold wild type site S1 (W) can compete effectively for binding of ELT-6 to S1 (compare lanes 2 and 3). Mutation of GATA site S1 (M1) reduces but does not abolish the ability to compete (lane 4). Mutation of both site S1 and a second GATA site on the oligonucleotide (M2) drastically reduces the ability of the oligonucleotide to compete for ELT-6 binding (lane 5).](1471-213X-14-17-6){#F6}

To examine regulation of *lin-39* expression by ELT-6 in the embryo, we assayed expression of a reporter construct containing the wild type 340 bp element, *pJW3.9::GFP*, in *elt-6*(*gk723*) mutant animals. *gk723* is an allele with 457 bp deletion covering the first intron and second exon of *elt-6* and is a presumed null mutation \[[@B57]\]. Only 56% of embryos from *elt-6*(*gk723*) mutant animals displayed a wild type pattern of *pJW3.9::GFP* expression, compared to 94% of control embryos (Figure [5](#F5){ref-type="fig"}F, Table [3](#T3){ref-type="table"}). A decrease in the penetrance of expression was also seen in the embryos derived from *pJW3.9::GFP* mothers treated with *elt-6* RNAi (78%; Table [3](#T3){ref-type="table"}). We also examined the effect of reduction of *elt-6* function on embryonic expression of the large *lin-39*::*GFP* reporter that we used to assay other transcription factors. When *elt-6* RNAi was performed on *lin-39*::*GFP* hermaphrodites, only 82% of embryos showed the wild type level of GFP expression in P5- P8 (Figure [5](#F5){ref-type="fig"}D, Table [2](#T2){ref-type="table"}). Taken together, these results indicate that the GATA factor ELT-6 is necessary for proper expression of *lin-39* in P5-P8 in the embryo, most likely via binding to the conserved GATA site in the *pJW3.9* enhancer, which was previously shown to be necessary for enhancer driven GFP expression in the embryonic P cells \[[@B47]\]).

The GATA factor EGL-18 also regulates *lin-39* expression in the P cells in the embryo
--------------------------------------------------------------------------------------

The *elt-6* open reading frame begins less than 600 bp downstream from the end of another GATA factor gene, *egl-18* (see Figure [7](#F7){ref-type="fig"}B), and these two genes are transcribed dicistronically in some tissues \[[@B55],[@B70]\]. The DNA binding domains of EGL-18 and ELT-6 are similar, and the two genes show genetic redundancy during fate specification of the hypodermal seam cells and VPCs \[[@B55],[@B70],[@B71]\]. In particular, reduction of function for both *elt-6* and *egl-18* in the larva causes the VPCs to adopt inappropriate cell fates and fuse with the hypodermal syncytium \[[@B55]\], a phenotype also seen with reduction of *lin-39* function \[[@B28],[@B45]\].

![**Direct transcriptional regulators of*lin-39*in the embryo and larva. A)** Horizontal lines represent 20 kb of genomic DNA surrounding the *lin-39* locus. The *lin-39* transcript is shown below the top line, with boxes representing exons. The next horizontal line shows evolutionarily-conserved regions (ECRs; thin vertical lines), the PCR fragments used in the yeast one hybrid assays containing the ECRs (boxes labeled 1--12), and two fragments (*pJW3.9* shown, JW5 unlabeled) identified previously using an enhancerless GFP assay \[[@B47]\]. Transcription factors that bind the *lin-39* gene are shown above the line (previously reported) or below the line (reported in this work). **B)** Model for positive feedback loop between *egl-18*/*elt-6* and *lin-39*. EGL-18 and ELT-6 act via the GATA site in enhancer *pJW3.9* to facilitate initiation of *lin-39* expression in the embryo, and then LIN-39 acts to positively regulate *egl-18*/*elt-6* expression via the Hox/Pbx binding site in the intron of *egl-18*\[[@B55]\].](1471-213X-14-17-7){#F7}

Although EGL-18 did not bind to the 340 bp *pJW3.9* fragment in yeast assays (Additional file [4](#S4){ref-type="supplementary-material"}: Table S5), the known functional redundancy of *elt-6* and *egl-18* and their dicistronic expression in hypodermal cells led us to test for a role for *egl-18* in the regulation of *lin-39* expression. When the *pJW3.9::GFP* reporter was moved into two different *egl-18* mutant strains, *egl-18(ga97)* and *egl-18(n162)*\[[@B55]\], we found that GFP expression in P5 - P8 in the embryo decreased from 94% for control animals to 60% in *egl-18(ga97)* and 68% in *egl-18(n162)* (Figure [5](#F5){ref-type="fig"}G and H, Table [3](#T3){ref-type="table"}). These results suggest that EGL-18 is also required for proper *lin-39* expression in the embryo. To test for redundant function in *lin-39* regulation, we performed RNAi for one gene in the background of a mutant for the other (because the genes are adjacent, we were unable to build *egl-18*; *elt-6* double mutant animals). In neither case was there a significant decrease in the number of embryos showing *pJW3.9::GFP* expression compared to the *egl-18* or *elt-6* mutant strain treated with control vector (Table [3](#T3){ref-type="table"}). Thus we did not obtain evidence for functional redundancy of *elt-6* and *egl-18* in regulating *pJW3.9::GFP* expression in the embryo, even though reduction of function for either gene alone affects embryonic GFP expression.

ELT-6 and EGL-18 also regulate *lin-39* expression post-embryonically
---------------------------------------------------------------------

We also examined whether *elt-6* affects *lin-39* expression post-embryonically. *elt-6* RNAi was performed on *lin-39::GFP* L1 larvae and we observed GFP expression in the VPCs in the same animals at the L3 stage. A statistically significant decrease in the number of VPCs (P5.p - P8.p) showing a wild type level of *lin-39::GFP* expression in the VPCs at the L3 stage was seen for *elt-6(L1 RNAi)* animals (Figures [2](#F2){ref-type="fig"}H and [3](#F3){ref-type="fig"}G), indicating that *elt-6* also positively regulates *lin-39* in the larval VPCs. EGL-18 is also likely to regulate *lin-39* expression postembryonically, since qRT-PCR on animals in which both *egl-18* and *elt-6* function is compromised had lower expression of *lin-39* than *elt-6*(*gk723*) mutant animals alone (Figure [4](#F4){ref-type="fig"}B).

To test the hypothesis that *lin-39* is a downstream target of ELT-6 and/or EGL-18 in the larva, we asked if overexpression of the GATA factors could increase *lin-39* levels. We overexpressed *egl-18* and *elt-6* using the heat shock promoter and assayed *lin-39* levels by qRT-PCR for *lin-39* one hour after a single heat shock at the L2/L3 molt. We found that *lin-39* levels went up 1.8 fold when ELT-6 was over-expressed, 1.6 fold when EGL-18 was over-expressed, and 1.7 fold when both ELT-6 and EGL-18 were over expressed (Figure [4](#F4){ref-type="fig"}C), supporting the hypothesis that *lin-39* is a downstream target of both ELT-6 and EGL-18 in the larval VPCs.

Discussion
==========

The *C. elegans* Hox gene *lin-39* functions in the midbody region of the developing *C. elegans* larva, where it is expressed in the P cells and their descendants, including the hermaphrodite vulval precursor cells (VPCs) \[[@B14]\]. During vulval development, *lin-39* expression is regulated by Wnt and Ras signaling pathways to facilitate VPC fate specification \[[@B26],[@B28],[@B45],[@B46]\]. To further understand the function of *lin-39* in hermaphrodite vulval development, we wish to identify cis-acting sites and trans-acting factors required for initiation, maintenance and regulated expression of *lin-39* in the P cells and VPCs. Previously, using an enhancerless GFP reporter assay, we identified a *lin-39* enhancer fragment (JW5) that directs expression in the VPC P6.p at the time of vulval induction, which responds to Ras pathway activity, and which is bound by the Ras pathway effectors LIN-1 and LIN-31, as well as by LIN-39 itself \[[@B47]\]. We also identified a *lin-39* enhancer (JW3.9) that directs expression in the P cells in the embryo and in their larval descendants (the VPCs and ventral cord neurons), and showed that expression in the embryo depended on an evolutionarily conserved site that contains within it a putative GATA transcription factor binding site.

Here we took a complementary approach to identify additional factors that may regulate *lin-39* expression during vulval development. We concentrated on 27 short, evolutionarily conserved regions (ECRs) that we previously identified in the *lin-39* gene in *C. elegans*, *C. briggsae* and *C. remanei*\[[@B47]\], on the assumption that some may represent binding sites for phylogenetically conserved transcriptional regulators. We used the yeast one-hybrid technique to identify transcription factors that could bind to DNA fragments containing one or more of these ECRs, circumventing the requirement that the DNA site be sufficient to direct *in vivo* reporter expression \[[@B53]\]. Having found multiple transcription factors that interact with *lin-39* DNA fragments, we looked for effects on endogenous *lin-39* transcript levels and on expression from a *lin-39::GFP* reporter *in vivo* when the function of these proteins was reduced. Using this approach we identified six transcription factors that bind *lin-39* promoter sequences in yeast and *in vitro* and regulate *lin-39* expression and/or function *in vivo* (Figure [7](#F7){ref-type="fig"}A, Table [1](#T1){ref-type="table"}). Three factors, the orphan nuclear receptor NHR-43, the hypodermal cell fate regulator LIN-26 and the GATA factor ELT-6 positively regulate *lin-39* expression in the embryo. In addition to those three factors, we identified the zinc finger proteins ZTF-17 and BED-3 and the T box factor TBX-9 as positive regulators of *lin-39* expression in the larval VPCs. Before this work, only four transcription factors were known to directly bind at the *lin-39* gene and regulate its expression; LIN-1, LIN-31, LIN-39 and TRA-1, all of which act during larval life (Figure [6](#F6){ref-type="fig"}B) \[[@B37],[@B47]\]. Therefore, by this approach combining phylogenetic conservation and yeast one-hybrid screening, we have more than doubled the number of factors known to directly bind to and regulate *lin-39*, and for the first time we have identified factors that regulate expression of this Hox gene in the embryo.

We believe these factors regulate *lin-39 in vivo* because we observed a reproducible change in expression of the full length *lin-39::GFP* reporter and/or a decrease in endogenous *lin-39* transcript levels when the function of each of these factors was reduced, and in several cases we observed a phenotype in a LIN-39 regulated process (prevention of VPC fusion). Given their binding to sites from the *lin-39* genomic region, the simplest model would be that these factors directly regulate *lin-39* expression in the cells we examined (Figure [7](#F7){ref-type="fig"}A). However, in the current work we did not pursue *in vivo* binding studies for any of these factors; although published results from the modENCODE project show binding of ALR-1 to the evolutionarily conserved site we identified at the relevant time in development \[[@B40],[@B63]\]. Additionally, while existing GFP reporters for four of these proteins (TBX-9, NHR-43, ALR-1 and ZTF-17) are turned on in some *lin-39*-expressing cells, expression in the P cells or VPCs has not been directly observed \[[@B57],[@B59],[@B61],[@B64],[@B67]\]. GFP reporters suffer from the caveat that all the elements required to recapitulate endogenous expression may not be present, or the expression may be weak or dynamic. However, until we can verify expression of each transcription factor in the embryonic P cells or larval VPCs, and show evidence of binding to the sites we identified *in vivo*, it remains possible that some of these factors regulate *lin-39* indirectly via another transcription regulator, or even act non cell-autonomously on *lin-39* expression. The strongest case for direct regulation can be made for BED-3, which regulates *lin-39* expression during larval life, and for LIN-26 and ELT-6, which regulate *lin-39* expression in the embryonic P cells.

BED-3
-----

*bed-3* encodes a 599 amino acid zinc finger protein with a BED DNA binding domain, and *bed-3* mutants show an Egl- laying (Egl) defective phenotype and defects in the terminal cell divisions of the descendants of the VPCs \[[@B68]\]. An intronic enhancer element from *bed-3* directs GFP expression in VPC descendants, leading to the hypothesis that BED-3 functions in the terminal cell divisions of vulval cells during vulval induction \[[@B68]\]. We found that *bed-3(RNAi)* showed the strongest effect on full length *lin-39::GFP* expression in the VPCs; in wild type animals the VPCs P5.p - P8.p showed lin-39::GFP expression 89% of the time (averaged over all four cells), while in *bed-3(RNAi)* animals these cells showed GFP expression only 37% of the time. This suggests that BED-3 could be acting at an earlier stage in vulval development. Consistent with this, we observed that the *bed-3 enhancer::GFP* reporter does show expression in the VPCs before they divide (Additional file [8](#S8){ref-type="supplementary-material"}: Figure S7), which would be consistent with BED-3 acting upstream of *lin-39* in the VPCs themselves. Therefore, although we could not verify BED-3 binding to the YF10 site *in vitro* with purified protein, we believe BED-3 is likely to be a positive regulator of *lin-39* in the larval VPCs before vulval induction, as well as functioning in the subsequent cell division of their progeny, as previously reported \[[@B68]\].

LIN-26
------

LIN-26 is a 438 amino acid zinc finger transcription factor that shows continuous expression in all embryonic and larval hypodermal cells after their birth \[[@B65]\]. Loss of *lin-26* causes hypodermal cells to adopt incorrect cell fates or degenerate after their birth, resulting in embryonic lethality \[[@B65],[@B66]\]. Ectopic expression of LIN-26 in the early embryo can induce cells to adopt hypodermal-like fates \[[@B72]\]. These results suggest that LIN-26 is required to specify and/or maintain the hypodermal cell fate \[[@B65]\]. *lin-26* itself is positively regulated by the GATA factor ELT-1, which is another global regulator of hypodermal cell fate \[[@B73]\]. We found that *lin-26* RNAi caused a weak but significant decrease in the expression of the full length *lin-39::GFP* reporter in the P cells in the embryo; 100% of wild type embryos show GFP expression, compared to 86% of *lin-26(RNAi)* animals. LIN-26 binds *in vitro* to a 51 bp sequence located approximately 2 kb upstream of the *lin-39* start codon (Figure [6](#F6){ref-type="fig"}B). Recent data recording reporter gene expression from live developing embryos shows that a *lin-26::mCherry* transcriptional reporter shows expression in the mothers of the P cells shortly before they divide, at the same time as these cells also begin to show expression of a *lin-39*:*:mCherry* reporter \[[@B74]\] (Additional file [9](#S9){ref-type="supplementary-material"}: Figure S8). Based on these results, and the known function of LIN-26 in hypodermal cell fate, we propose that LIN-26 positively regulates *lin-39* expression in the embryonic P cells, and that the function of this regulation is to aid in initial P cell fate specification and/or to maintain the P cell identity once established.

ELT-6
-----

*elt-6* encodes a 367 amino acid GATA family transcription factor. The *elt-6* gene is immediately downstream from another GATA factor gene, *egl-18* (Figure [7](#F7){ref-type="fig"}B), and reporter gene experiments suggest *elt-6* may be expressed on its own and as part of a dicistronic message with *egl-18*\[[@B70]\]. These genes are expressed in many cells in the embryo, including the descendants of the MS and AB blastomeres (which give rise to the P cells). In the larva, they are expressed strongly in the lateral hypodermal seam cells and weakly in the VPCs \[[@B55],[@B70]\]. These two GATA factors share 76% identity in their DNA-binding domains, and have been shown to act redundantly in seam cell development in both the embryo and larva \[[@B70],[@B71]\]. We previously showed that a 340 bp *lin-39* enhancer (JW3.9) directs GFP expression in the embryonic P cells, and a conserved GATA site in the enhancer was necessary for expression \[[@B47]\]. Here we identify the GATA factor ELT-6 as binding to this *lin-39* enhancer in yeast and *in vitro*, and show that binding was dependent on the GATA sequence. *elt-6* RNAi showed a decrease in expression of the full length *lin-39::GFP* reporter in embryonic P cells, and this result was recapitulated with the *pJW3.9* reporter in *elt-6*(*gk723*) mutant and *elt-6(RNAi)* embryos. These data suggest that ELT-6 is required for proper expression of the Hox gene *lin-39* in the embryonic P cells. Consistent with this, recent data from live recordings of developing embryos shows that *elt-6* expression in the mothers of P3 - P8 begins before *lin-39* expression is first seen (\[[@B74]\]; Additional file [8](#S8){ref-type="supplementary-material"}: Figure S7). This is the first example to our knowledge of a phenotype caused by reduction of *elt-6* function alone. *elt-6* RNAi treatment of newly hatched L1 larvae also led to a weak reduction in *lin-39::GFP* expression in the L3 VPCs, and overexpression of ELT-6 or EGL-18 increased endogenous *lin-39* expression in larvae. These results suggest that ELT-6 and/or EGL-18 may continue to positively regulate *lin-39* expression in larval life in the VPCs.

Given these results, it is interesting that we previously showed, in collaboration with the Rothmann laboratory, that the *egl-18*/*elt-6* locus was likely to be a downstream target of LIN-39 in the larval VPCs \[[@B55]\]. In that work an 800 bp enhancer element was identified in intron 2 of the *egl-18* gene that directs GFP expression in the VPCs and their descendants starting in the L2 stage. This enhancer contains two Hox protein-binding sites that are bound *in vitro* by LIN-39 and its binding partner CEH-20, and mutation of one site eliminated enhancer-driven GFP expression. Finally, overexpression of *egl-18* from the heat shock promoter was able to partially rescue vulval defects in *lin-39(RNAi)* animals. These data led to the model that *egl-18*/*elt-6* is a downstream target of LIN-39 during vulval development.

Combining these previous data with our current results, our working model suggests LIN-26 and ELT-6 are involved in the initiation of expression of the Hox gene *lin-39* in the P cells in the embryo (Figure [7](#F7){ref-type="fig"}A). *lin-39* may also be regulated by EGL-18 at this time, since *egl-18* mutants had reduced enhancer-driven GFP expression in the P cells, and EGL-18 protein bound to the *pJW3.9* GATA site *in vitro* (W. Liu and D. Eisenmann, unpublished results). Once the fate of these cells is established, a positive feedback loop is established between ELT-6, acting via the upstream *lin-39* enhancer *pJW3.9*, and LIN-39, acting via the intronic enhancer in *egl-18*\[[@B55]\]. We propose that this positive feedback loop helps maintain expression of these genes and the fate of these cells and their descendants, the VPCs, during subsequent embryonic and larval development (Figure [7](#F7){ref-type="fig"}B). Interestingly, we have seen another example of *lin-39* feedback regulation. The zinc finger protein SEM-4 was previously shown to positively regulate *lin-39* expression in VPCs \[[@B49]\]. We have found that in animals overexpressing either LIN-39 or LIN-39 and CEH-20, *sem-4* expression is decreased, suggesting that feedback mechanisms to decrease *lin-39* levels when they are elevated may also exist (J. Siegel and D. Eisenmann, unpublished results). Recent chromatin immunoprecipitation experiments from larvae verify binding of tagged LIN-39 protein upstream and in introns of both the *egl-18* and *sem-4* genes \[[@B40],[@B63]\].

Conclusion
==========

While much is known about the initiation and regulation of Hox gene expression in Drosophila and vertebrates, less is known outside of these well-studied groups. Our laboratory and others have been studying the expression and function of the Hox gene *lin-39* during vulval development in the nematode *C. elegans*. We used the yeast one-hybrid (Y1H) method to identify 16 transcription factors that interact with specific regions of the *lin-39* gene, and further characterized several factors (ALR-1, BED-3, ELT-6, LIN-26, NHR-43, TBX-9 and ZTF-17) showing that their function is required for proper expression of *lin-39::GFP* reporters and endogenous *lin-39 in vivo*. This work greatly expands the number of factors known to directly regulate *lin-39* expression. Given the known caveats of the yeast one-hybrid technique (absence of specific posttranslational modifications, lack of heterodimeric binding factors), and our emphasis on characterization of factors with known expression or phenotypes in the vulval cells, it is likely that there are additional factors that regulate *lin-39* in the embryo and larva that we did not identify in our screens. Given the important role of Hox genes in patterning the developing metazoan body, it is not surprising that Hox gene expression is found to be complicated in those species where it has been examined closely. Our results suggest that expression of the *C. elegans* Hox gene *lin-39* in the P cells and VPCs during vulval development may be regulated by a large number of transcription factors, each making a small contribution to overall *lin-39* expression on its own. This is consistent with *in vivo* data from *C. elegans* showing that the average worm gene is bound by several transcription factors at one time in larval development \[[@B40],[@B63]\]. Such a mechanism may ensure a robustness of expression for important developmental regulators like Hox genes. Transcription factors behaving in this manner would also not be identified in genetic screens, since each makes a small overall contribution to *lin-39* expression, and feedback mechanisms may exist to compensate for reductions in *lin-39* transcript levels. Finally, for the first time, we have identified factors required for *lin-39* expression in the embryo (NHR-43, LIN-26 and ELT-6), and our results with EGL-18 and ELT-6, combined with our earlier work on LIN-39 regulation of *egl-18*/*elt-6*, hint at a positive feedback mechanism to maintain *lin-39* expression in the vulval lineages. The identification of LIN-26, ELT-6, and NHR-43 will help us further characterize the mechanisms for the initiation of Hox gene expression in the nematode, allowing us to make comparisons across metazoan phyla about the mechanisms utilized to regulate this essential class of developmental regulators.

Methods
=======

Yeast one-hybrid (Y1H) assays
-----------------------------

Y1H assays were performed using two methodologies: a traditional library 'transformation' screen, and a robotically-assisted 'mating' screen ("enhanced" Y1H, eY1H). Briefly, each DNA fragment of interest (YF1 - YF12, *pJW3.9*; see Additional file [1](#S1){ref-type="supplementary-material"}: Figure S1) was cloned into reporter vectors pMW\#2 (*HIS3*) and pMW\#3 (*LacZ*) and the resulting constructs were sequentially integrated into the genome of yeast strains BY5444 and YM4271 to generate thirteen "DNA bait" strains. BY5444 and YM4271 are isogenic for multiple marker genes (*MATa ura3-52 his3-200 ade2-101 lys2-801 leu2-3,112 trp1-901 tyr1-501 gal4-Δ512 gal80-Δ538 ade5::hisG*) but BY5444 does not mate efficiently with the Yalpha1867 strain used in eY1H assays.

The 'transformation' screen was performed as described \[[@B53]\]. Each of the thirteen bait strains (BY5444 background) was transformed with DNA from a commercially-available, *C. elegans* transcription factor library containing 755 plasmids that each express one *C. elegans* transcription factor fused in frame with the yeast GAL4 activation domain (Open Biosystems; \[[@B75]\]). Potential interactions were identified as those colonies that turned blue on plates containing X-Gal, and which grew on plates containing a higher concentration of 3-aminotriazole than the control strain grew on. The eY1H screens were performed as described \[[@B54]\]. Each of the thirteen bait strains (both BY5444 and YM4271 backgrounds) was mated with a collection of 936 Y1Halpha1867 strains of the opposite mating type, each of which expresses a single *C. elegans* transcription factor fused to the GAL4 activation domain. Matings were done in quadruplicate. Potential interactions were identified as those for which at least two of the four colonies exhibited higher expression of both reporters than control yeast, as assayed by blue color and growth on SC-His + 5 mM 3-aminotriazole + X-Gal. For both methods, plasmids were recovered from positive yeast, sequenced to identify the *C. elegans* gene, and then retransformed back into the appropriate yeast strain to confirm the interaction. From both screens, only those interactions that repeated after retransformation were considered true positives. For the haploid transformation screen, while most baits gave many 3-aminotriazole resistant colonies, only RF1, RF2, RF4 and RF6 gave double positive colonies, and only interactions with NHR-43, ALR-1 and ZTF-17 repeated (all three factors were identified multiple times). For the robotically assisted mating screens, the results are presented in Additional file [4](#S4){ref-type="supplementary-material"}: Table S2-S4.

Genetic methods, alleles and strains
------------------------------------

Methods for culture and genetic manipulation of *C. elegans* were performed as described \[[@B76]\]. Bristol variety (strain N2) of *C. elegans* was used as wild-type. Experiments were performed at 20°C unless noted. Genes and alleles used in this work are described in \[[@B77]\] and Wormbase \[[@B57]\].

LGII*: rrf-3(pk1426), lin-26(n56)*

LGIII: *tbx-9(ok2473), tbx-9(ms31), unc-119(ed3), pha-1(e2123), lin-39(n709ts)*

LGIV: *nhr-43(tm1381), bed-3(sy702), bed-3(sy705), elt-6(gk723), egl-18(ga97), egl-18(n162), egl-18(ok290)*

LGX: *alr-1(ok545)*

Strains used:

*lin-39::GFP*: *smg-1(e1228); him-5(e1490); deIs4\[lin-39TN::GFP; dpy-20(+); ajm-1::GFP\]*\[[@B46]\]

*nhr-43::gfp: unc-119(ed3); Ex\[C29E6.5::gfp; unc-119 (+)\]*\[[@B64]\]

*bed-3::GFP: unc-119(ed3); syEx962\[pTI06.29; unc-119(+); pBSKSII(+)\]*\[[@B68]\]

*pJW3.9::GFP*: *pha-1(e2123); deEx105\[pJW3.9::gfp; pha-1(+); ajm-1::GFP\]*\[[@B47]\]

Strains created for this work:

hs::control: unc-119(ed3); deEx106\[pPD49.78; unc-119(+); ajm-1::GFP\]

hs::elt-6: unc-119(ed3); deEx107\[pLG1; unc-119(+), ajm-1::GFP\]

hs::egl-18: unc-119(ed3); deEx108\[pPK8; pPK9; unc-119(+); ajm-1::GFP\]

hs::egl-18+ hs::elt-6: unc-119(ed3); deEx109 \[pLG01; pKK8; pKK9 unc-119 (+); ajm-1::GFP\]

RNA interference
----------------

RNA interference *(RNAi)* was performed using the bacterial 'feeding' method in which dsRNA for the gene of interest is produced in *E. coli* strain HT115 and ingested by worms \[[@B78]\]. For feeding of L1 larvae, eggs from strains to be tested were placed on plates without *E. coli* for at least 18 hours at 20°C, then semi-synchronized L1 larvae were washed off, placed onto plates with the desired HT115 RNAi strain and grown at 20°C to the appropriate stage for scoring. For feeding of P0 animals, L1 stage P0 larvae were put onto the desired RNAi plates, grown to adulthood and their F1 progeny were analyzed at the appropriate stage.

Reporter gene analysis
----------------------

Worms carrying GFP reporter constructs were analyzed using fluorescence microscopy on a Zeiss Axioplan 2 at the desired developmental time. GFP expression in live animals was captured using a Nikon DXM 1200 digital camera and the ACT-1 program (version 2.12). For *deIs4* \[*lin-39::GFP*\] and *pJW3.9::GFP* reporter analysis, the percentage of animals showing an intensity of expression similar to wild-type was determined. For embryonic expression in the cells P5 - P8 the number of embryos showing wild type expression in all four cells was recorded. For larval expression in the cells P5.p - P8.p the intensity of GFP expression in the individual cells at the L3 stage was analyzed using ImageJ \[[@B79]\] and pixel counts for each cell were recorded (after subtraction of background). For each RNAi treatment, at least 20 animals at the L3 stage were photographed, under identical conditions. Expression data was statistically analyzed using an unpaired *t*-test and both P values and SD were gathered. All *deIs4* experiments were carried out in a *smg-1* mutant background, in which nonsense-mediated decay is abrogated, leading to more robust reporter expression \[[@B46]\].

Creation of strains expressing EGL-18 and ELT-6 from the heat shock promoter
----------------------------------------------------------------------------

For heat-shock induced expression of EGL-18, we used the previously described constructs pKK8 and pKK9 in which the entire coding region of *egl-18* is inserted into the heat shock promoter vectors pPD49.78 and pPD49.83 respectively \[[@B55]\]. A similar heat shock expression construct, pLG1 (gift of L. Gorrepati), was made by cloning *elt-6* genomic DNA from the start to stop codon into vector pPD49.78 (available at \[[@B80]\]; gift of A. Fire, Stanford University School of Medicine, Stanford, CA). To create transgenic strains, DNA for these constructs was co-injected at 25 ng/ul with *unc-119 (+)* (100 ng/ul) and *ajm-1::gfp* DNA (50 ng/ul) \[[@B81]\] into *unc-119(ed3)* hermaphrodites. For the *hs::control* strain, the empty heat-shock vector pPD49.78 was used. For the *hs::elt-6 + hs::egl-18* strain, pLG1, pKK8 and pKK9 were injected together. Several lines rescued for the Unc phenotype were recovered for each injection and the ones with the highest percentage transmission to progeny were analysed.

Heat shock protocol
-------------------

Embryos from transgenic animals containing the arrays *hs::control, hs::elt-6, hs::egl-18,* and *hs::elt-6 + hs::egl-18* were collected from hypochlorite-treated gravid animals and hatched on NGM plates without food for at least 18 hours at 20°C, allowing for early L1 stage arrest. Synchronized L1 animals were fed with OP50, grown to the early L3 stage (25 hours post feeding at 20°C), heat shocked at 33°C for 30 minutes, then transferred back to 20°C and collected 30 minutes later for RNA isolation.

RNA isolation
-------------

For genes with existing mutant strains, animals were synchronized and grown to early L3 stage (26 hours after feeding at 20°C) to be collected. For genes without existing mutant strains, RNAi was performed on wild type worms. For heat shocked worms, animals were treated with the heat shock program described above. Three biological replicates were performed for each strain and RNA was extracted using the RNAeasy mini kit (Qiagen).

qRT-PCR
-------

The mRNA fraction of extracted total RNA pools was reverse transcribed to cDNA using iScript™ cDNA synthesis kit (Bio-Rad) and used in triplicate qRT-PCR reactions run on an iCycleriQ real-time PCR machine (BioRad). Relative expression ratios were calculated from observed Ct values using the ΔΔCt method \[fold change = (E~target~) ^targetΔCt\ (control-sample)^/ (E~ref~) ^RefΔCt\ (control-sample)^\[[@B82]\]\] with the house keeping gene *gpd-2* as a reference \[[@B83]\]. For mutant strains, N2 animals were the control. For RNAi-treated worms, N2 animals treated with the empty RNAi 'feeding vector' (L4440) (available at \[[@B80]\]; gift of A. Fire, Stanford University School of Medicine, Stanford, CA) were the control. For heat shocked strains, *hs::control* animals which underwent the heat shock treatment were the control. Three biological replicates were used for each sample. The data was statistically analyzed using unpaired *t*-test and both P values and SD were gathered with Graphpad software. Primers for *gpd-2* and *lin-39* were *gpd-2*FW (CCTCTGGAGCCGACTATGTC), *gpd-2*RV (TGGCATGATCGTACTTCTCG), *lin-39*FW (CGGAGATCAGTCACTATGCT) and *lin-39*RV (CCGCGTGAACCTCCTGTAGT).

Site direct mutagenesis
-----------------------

Site directed mutagenesis was performed using the Quick Change site directed technique following manufacturer's instructions with the high fidelity DNA polymerase Pfu Turbo (Stratagene). Plasmid DNA was extracted and sequenced to confirm the presence of mutations.

Protein purification
--------------------

Full length cDNAs for *nhr-43*, *alr-1*, *ztf-17*, *lin-26*, *bed-3*, *tbx-9*, and *elt-6* were obtained by PCR amplification from plasmids obtained from the Open Biosystems Y1H library \[[@B75]\] and cloned individually into the plasmid pQE-80 L (Qiagen), which introduces a 6His tag at the N terminus. Plasmids were transformed into *E. coli* strain BL21, grown to an OD of 0.7 and induced with 1 mM IPTG for 4 hours. For purification of NHR-43, ALR-1, LIN-26, BED-3, TBX-9, and ELT-6, cells were centrifuged, resuspended in lysis buffer (50 mM, NaH~2~PO~4~, 300 mM NaCl, 10 mM imidazole, pH 8.0 plus protease inhibitors \[Sigma\]), sonicated for 3 minutes on a Branson Sonifier 450, and centrifuged. The supernatant were collected and loaded on a Ni^2+^-NTA agarose column (Qiagen), washed five times with wash buffer (50 mM NaH~2~PO~4~, 300 mM NaCl, 20 mM imidazole, pH 8.0) and eluted with elution buffer (50 mM NaH~2~PO~4~, 300 mM NaCl, 250 mM imidazole, pH 8.0). For purification of ZTF-17, cells were centrifuged, resuspended in sonication buffer (20 mM Tris 7.9, 500 mM NaCl), sonicated and centrifuged. The pellet was resuspended in solubilizing buffer (6 M Guanidine, 20 mM Tris 7.9, 300 mM NaCl, 5 mM Imidazole, 5% glycerol plus protease inhibitors \[Sigma\]). Insoluble material was pelleted by centrifugation and the supernatant was loaded onto a Ni^2+^-NTA agarose column, washed five times with buffer and eluted with elution buffer 2(6 M Guanidine, 300 mM NaCl, 300 mM Imidazole, 40% glycerol, 20 mM HEPES pH7.5). Protein was diluted to 0.5 mg/ml with elution buffer, dialyzed at 4°C overnight against dialysis buffer (20 mM HEPES pH7.5, 300 mM NaCl, 40% glycerol) and concentrated to 500 ng/ul using a Centricon-10.

The primers for cDNA amplification were:

NHR-43: FW:GCGCGGATCCATTAGCGGCCCATTTCTTCAC/RV: GCGCGCAAGCTTTTAGATTGAGTACAAGTAGGC

ALR-1: FW: GCGCGCATGCCCCGAGTTGAAGAAAGAAGA/RV: GCGCGCAAGCTTTCATGAACTTTCTTCTTTTG

ZTF-17: FW: GCGCGCATGCCTGCGCTACCAGGCGTCCGTG/RV:CGCCCCGGGCTATTTTACTCTAAGAAATA

LIN-26: FW: GCGCGCATGCCTTTCTAAATTTGTGGTAGTC/RV: CGCCCCGGGCTACACCAATGGTTGAGCCAT

TBX-9: FW: GCGCGAGCTCTCCAAAGTCAAAGTATCA/RV: CGCCCCGGGTCAACCAACAATATCAAT

BED-3: FW: GCGCGCATGCCAGACCCAAAGTCCATTT/RV: CGCCCCGGGTCAAACAAGTTGATCAAT

ELT-6: FW: GCGCGCATGCACGTCGTCGAAGGAGGAGATG/RV: CGCCCCGGGTCAGGGAGACTTGCGCTGCTC

Electrophoretic mobility shift assays
-------------------------------------

For DNA probes larger than 100 bp, DNA fragments were produced by PCR, and 5 pmole was labeled with ^32^P using T4 polynucleotide kinase (NEB). For DNA probes less than 100 bp, one oligonucleotide was labeled with ^32^P, then annealed with the complementary oligonucleotide. The labeled double stranded DNA probes were purified using Centri-Spin-20 columns (Princeton Separation), and their activity was measured using a standard scintillation counter. The oligonucleotides used to make EMSA probes are listed in Additional file [5](#S5){ref-type="supplementary-material"}: Figure S6.

DNA binding reaction were set up at 4°C in a volume of 20 ul in final buffer conditions of 50 mM KCl, 20 mM HEPES, pH 7.9, 0.2 mM EDTA, 0.5 mM DTT, 3 mM MgCl~2~, 1 μg poly(dI--dC), 0.5 μg/ul BSA, 5000 cpm ^32^P-labeled DNA probe and 0--800 ng of protein. Reactions were incubated 20 minutes on ice, then loaded onto 4.5% (probe size smaller than 100 bp) or 6% (probe size larger than 100 bp) polyacrylamide gels. Gels were run in 0.5xTBE buffer at 150 V for 2.5 hours (4.5% gel), or 220 V for 2 hours (6% gel), dried and analyzed using a Storm 860 phosphorimager (Molecular Dynamics). For competitive binding experiments, the indicated concentration of cold competitor was added to the reaction before the protein.

VPC fusion assay in lin-39 sensitized background
------------------------------------------------

For *nhr-43*, *alr-1*, *ztf-17*, *tbx-9*, *elt-6* and control RNAi, P0 *lin-39(n709ts)*; *wIs79(ajm-1::GFP)* larvae were grown to adulthood at 25°C on the desired RNAi plates, then semi-synchronized F1 progeny were grown to the late L2 stage, when *ajm-1::GFP* expression in the vulval precursor cells was examined (17 hours post feeding). For *bed-3* and *lin-26* RNAi, *lin-39(n709ts)*; *wIs79(ajm-1::GFP)* eggs were hatched in M9 overnight at 20°C, then semi-synchronized L1 larvae were washed off, placed onto plates with the desired HT115 RNAi strain and grown at 25°C to the late L2 stage and scored. At least 25 animals were scored for each RNAi treatment using fluorescence microscopy on a Zeiss Axioplan 2. Wild type animals have either 5 or 6 VPCS with *ajm-1::GFP* expression at this time (due to fusion of P3.p with hyp7). The percentage of animals lacking *ajm-1:: GFP* expression in P4.p - P8.p was determined. The data was statistically analyzed using Fisher's exact test. 2X2 contingency tables were analyzed using Fisher's exact test and P values were gathered.
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###### Additional file 1: Figure S1

*lin-39* genomic region and fragments used in yeast one-hybrid screens. The top line shows 26 kb around the *lin-39* locus with base locations on chromosome II shown. Two *lin-39* transcripts and the upstream microRNA gene *mir-231* are diagrammed below. JW1-10 (bottom) are *lin-39* genomic regions previously used in reporter gene analysis*;* those in green drove GFP expression *in vivo* in *lin-39* expressing cells \[[@B47]\]. *pJW3.9* (orange box) is a 340 bp subfragment that drove GFP expression in P5 -- P8 in the embryo \[[@B47]\]. Thirty-one evolutionarily-conserved regions (ECRs) with \>75% identity in the *lin-39* gene from three *Caenorhabditis* species were previously identified \[[@B47]\]. ECRs are shown on the middle line as unlabeled, vertical black lines. Twenty-seven ECRS were grouped into 12 PCR fragments (numbered 1--12; red boxes). The twelve fragments (YF1-12) and *pJW3.9* were used as 'baits' in Y1H screens.
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###### Additional file 2: Figure S2

Fourteen transcription factors interact with *lin-39* genomic fragments in yeast one-hybrid assays (strain BY5444). Thirteen strains in background BY5444 containing fragments (YF1 - 12, *pJW3.9*) from the *lin-39* genomic region were screened for interactions with *C. elegans* transcription factors by both the haploid library transformation method, and the robotically-assisted mating method (see Methods). Any positive interactions from primary screens were retested by retransformation of the rescued interacting plasmid back into the appropriate 'bait' strain (see Additional file [4](#S4){ref-type="supplementary-material"}: Table S2). Shown here are three-fold serial dilutions of each strain grown on SC--His-Ura-Trp plates with no 3AT (control plates), SC--His-Ura-Trp with 10 mM 3AT, and plates with X-gal. Bait strains transformed with the pDEST-AD empty vector were the 'Control'. Positive interactions were considered those showing more growth on 3AT and/or more blue color on XGal than the control. Note that the YF8 strain shows considerable self-activation on 3AT, but positive interactions for NHR-111 and FLH-1 are observable on the XGal plates.
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###### Additional file 3: Figure S3

Four transcription factors interact with *lin-39* genomic fragments in yeast one-hybrid assays (strain YM4271). Thirteen strains in background YM4271 containing fragments (YF1 - 12, *pJW3.9*) from the *lin-39* genomic region were screened for interactions with *C. elegans* transcription factors by the robotically-assisted mating method (see Methods). Positive interactions from the primary screen were retested by retransformation of the rescued interacting plasmid back into the appropriate 'bait' strain (see Additional file [4](#S4){ref-type="supplementary-material"}: Table S3). Shown here are three-fold serial dilutions of each strain grown on SC--His-Ura-Trp plates with no 3AT (control plates), SC--His-Ura-Trp with 10 mM 3AT, and plates with X-gal. Bait strains transformed with the pDEST-AD empty vector were the 'Control'. Positive interactions were considered those showing more growth on 3AT and/or more blue color on XGal than the control.
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###### Additional file 4: Table S1

Sequences of 12 YFs and *pJW3.9*. **Table S2.** Yeast one-hybrid screen with strain BY5444 (screen YM2). **Table S3.** Yeast one-hybrid screen with strain YM4271 (screen YM2). **Table S4.** Summary of yeast one-hybrid screen results. **Table S5.** Only GATA factor ELT-6 binds *pJW3.9* in yeast*. elegans* GATA factors. **Table S6.** Oligonucleotides for EMSA probes.
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###### Additional file 5: Figure S6

TBX-9 binds a 79 bp region in fragment YF9. A) The top line shows fragment YF9 and the location of ECRs 21 -- 23. Subfragments A -- D are diagrammed below. Shading indicates the fragment bound by TBX-9 *in vitro*; B) Gel mobility shift assay with TBX-9 protein purified from *E. coli* and labeled fragment YF9 (lane 2) and competition with subfragments A -- D (lanes 3--6)*.* Arrowhead indicates free probe; arrow indicates the protein DNA complex that can be competed by fragment C. Two other bands appear with added TBX-9 protein: the upper band is competed away by all four competing fragments, while the lower band is competed by none of the fragments. The nature of these complexes is unknown, although they are likely to represent non-specific binding by TBX-9 or another protein. C) Gel mobility shift assay with TBX-9 protein and labeled fragment subfragments A -- D*.* The bracket indicates the migration locations of free probes (which differ in size, see panel A). Arrow indicates a complex with TBX-9 and subfragment C.
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###### Additional file 6: Figure S4

ZTF-17 binds to fragment YF4-4 in yeast. BY5444 'bait' strains containing subfragments of YF1 (YF4-1 to YF4-4; see Figure [1](#F1){ref-type="fig"}) were made and transformed with the plasmid encoding ZTF-17::Gal4AD or with the pDEST-AD empty vector as control. Three-fold serial dilutions of each strain grown on SC--His-Ura-Trp plates with no 3AT (control plates), SC--His-Ura-Trp with 10 mM 3AT, and plates with X-gal are shown. Fragment YF4-1 shows strong self-activation on 3AT. Only fragment YF4-4 shows a strong interaction with ZTF-17 on both 3AT and XGal plates.
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###### Additional file 7: Figure S5

LIN-26 binds to fragment YF4-3 using yeast. BY5444 'bait' strains containing subfragments of YF1 (YF4-1 to YF4-4; see Figure [1](#F1){ref-type="fig"}) were made and transformed with the plasmid encoding LIN-26::Gal4AD or with the pDEST-AD empty vector as control. Three-fold serial dilutions of each strain grown on SC--His-Ura-Trp plates with no 3AT (control plates), SC--His-Ura-Trp with 10 mM 3AT, and plates with X-gal are shown. Fragment YF4-1 shows strong self-activation on 3AT. Only fragment YF4-3 shows a strong interaction with LIN-26 on both 3AT and XGal plates.
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###### Additional file 8: Figure S7

*bed-3::GFP* expression in the larval VPCs. Expression from strains carrying *syEx962* which contains the *bed-3::GFP* reporter pTI06.29 \[[@B68]\]. GFP expression is seen in the Pn.p cells in the L1 stage (A) and L2 stage (B), including the VPCs P3.p - P8.p (indicated by white bars).
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###### Additional file 9: Figure S8

Expression of transcription factor genes *elt-1, elt-3, lin-26* and *lin-39* in the ABpra lineage in developing embryos. The images shown are taken directly from the Expression Patterns in Caenorhabditis web site \[[@B84]\]. As described \[[@B74]\], live images were recorded from developing embryos that expressed a histone:mCherry fusion protein driven from the upstream promoter sequences for each of the indicated genes. Expression levels in individual embryonic cells were characterized and diagrammed on the cell lineage chart. An expression scale for all experiments is shown at the top and shows the fluorescence intensity of the reporter construct in the individual cells; time (in minutes) for each experiment is shown along the left. The data shown are from the following experiments: 20080128_elt-1_3.html, 20070817\_*elt-6*\_5.html, 20080805\_*lin-26*\_5_L1.html and 20071015\_*lin-39*\_9.
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